SE356979B - - Google Patents

Info

Publication number
SE356979B
SE356979B SE15032/68A SE1503268A SE356979B SE 356979 B SE356979 B SE 356979B SE 15032/68 A SE15032/68 A SE 15032/68A SE 1503268 A SE1503268 A SE 1503268A SE 356979 B SE356979 B SE 356979B
Authority
SE
Sweden
Application number
SE15032/68A
Inventor
K Weber
K Zeile
P Danneberg
R Giesemann
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE356979B publication Critical patent/SE356979B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
SE15032/68A 1967-11-24 1968-11-06 SE356979B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1064767A AT280290B (en) 1967-11-24 1967-11-24 Process for the preparation of new 1-phenyl-4-alkyl-3H-1,4-benzodiazepine-2,5- [1H, 4H] -diones

Publications (1)

Publication Number Publication Date
SE356979B true SE356979B (en) 1973-06-12

Family

ID=3623762

Family Applications (1)

Application Number Title Priority Date Filing Date
SE15032/68A SE356979B (en) 1967-11-24 1968-11-06

Country Status (13)

Country Link
AT (1) AT280290B (en)
BE (1) BE724364A (en)
BR (1) BR6804236D0 (en)
CH (1) CH523265A (en)
DE (1) DE1810423B2 (en)
DK (1) DK124950B (en)
ES (2) ES360410A1 (en)
FR (2) FR1593335A (en)
GB (1) GB1173540A (en)
IE (1) IE32504B1 (en)
IL (1) IL31146A (en)
NL (1) NL6815755A (en)
SE (1) SE356979B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914216A (en) * 1962-12-18 1975-10-21 Boehringer Sohn Ingelheim 1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones
DE2117438A1 (en) * 1971-04-08 1972-10-19 CH. Boehringer Sohn, 6507 Ingelheim New substituted 1,3-dihydro-2H-1 ^ -benzodiazepine ^ -ones
BE793460A (en) * 1971-12-29 1973-06-28 Boehringer Sohn Ingelheim NEWS 1-ARYL-3H, 1,4-BENZODIAZEPINE-2,5- (1H
US7572788B2 (en) 1999-04-30 2009-08-11 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US7276348B2 (en) 1999-04-30 2007-10-02 Regents Of The University Of Michigan Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
DE60042425D1 (en) * 1999-04-30 2009-07-30 Univ Michigan Use of benzodiazepines for the treatment of autoimmune diseases, inflammation, neoplasia, viral infections and atherosclerosis
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
US7691582B2 (en) 2002-09-27 2010-04-06 The Regents Of The University Of Michigan Methods of secretory vimentin detection and modulation
AU2006203946B2 (en) 2005-01-03 2009-07-23 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
WO2007053193A2 (en) 2005-06-01 2007-05-10 The Regents Of The University Of Michigan Unsolvated benzodiazepine compositions and methods
AU2006308655B2 (en) 2005-11-01 2010-09-23 The Regents Of The University Of Michigan Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
WO2007146167A1 (en) 2006-06-09 2007-12-21 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
WO2008112553A1 (en) 2007-03-09 2008-09-18 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
EP2146722A4 (en) * 2007-05-10 2011-08-03 Amr Technology Inc Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
WO2009036175A2 (en) 2007-09-14 2009-03-19 The Regents Of The University Of Michigan F1f0-atpase inhibitors and related methods
RU2010122902A (en) 2007-11-06 2011-12-20 Дзе Риджентс оф дзе Юниверсити оф Мичиган (US) BENZODIAPENININE COMPOUNDS APPLICABLE IN TREATMENT OF SKIN CONDITIONS
JP5567573B2 (en) 2008-09-11 2014-08-06 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Arylguanidine F1F0-ATPase inhibitors and methods related thereto
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
US8673897B2 (en) 2009-09-18 2014-03-18 The Regents Of The University Of Michigan Benzodiazepinone compounds and methods of treatment using same
EP2501695B1 (en) 2009-11-17 2018-08-29 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
CN102753179A (en) 2009-11-17 2012-10-24 密执安大学评议会 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
CA2923835C (en) * 2013-09-11 2022-11-29 The Administrators Of The Tulane Educational Fund Novel anthranilic amides and the use thereof

Also Published As

Publication number Publication date
IE32504B1 (en) 1973-08-22
IL31146A (en) 1972-04-27
IE32504L (en) 1969-05-24
BR6804236D0 (en) 1973-02-08
FR1593335A (en) 1970-05-25
DE1810423C3 (en) 1973-10-11
NL6815755A (en) 1969-05-28
DE1810423A1 (en) 1969-10-09
CH523265A (en) 1972-05-31
AT280290B (en) 1970-04-10
ES360410A1 (en) 1970-11-01
DK124950B (en) 1972-12-11
ES378977A1 (en) 1973-01-16
BE724364A (en) 1969-05-22
IL31146A0 (en) 1969-01-29
GB1173540A (en) 1969-12-10
FR8310M (en) 1970-11-23
DE1810423B2 (en) 1973-03-22

Similar Documents

Publication Publication Date Title
AU425114B2 (en)
BE724364A (en)
AT298283B (en)
AU416737B2 (en)
AU610966A (en)
BE692552A (en)
BE692409A (en)
BE710614A (en)
BE710410A (en)
BE710310A (en)
BE710224A (en)
BE710000A (en)
BE709730A (en)
BE709564A (en)
BE709526A (en)
BE703561A (en)
SE366316B (en)
BE692779A (en)
BE692778A (en)
BE692654A (en)
BE692577A (en)
BE692553A (en)
BE703706A (en)
BE692493A (en)
BE692492A (en)